Home/Pipeline/Liquid Biopsy Innovation (Pleural Fluids)

Liquid Biopsy Innovation (Pleural Fluids)

Gastric and Pancreatic Cancer

ResearchActive

Key Facts

Indication
Gastric and Pancreatic Cancer
Phase
Research
Status
Active
Company

About Pangaea Oncology

Pangaea Oncology is a private, revenue-generating company positioned as a precision oncology service provider and diagnostic developer in Southern Europe. Its core activities include a clinical reference laboratory offering comprehensive molecular diagnostics and companion diagnostics, and a preclinical services division (Pangaea Lab) specializing in biomarker discovery, organoid technology, and in-vitro testing. The company leverages its integrated clinical and R&D capabilities to serve both healthcare providers and pharmaceutical partners, with a strategic vision centered on data exploitation and AI to advance personalized cancer treatment.

View full company profile

Therapeutic Areas